Insider · CIK 0001465914
Davis Aaron I.
Reports to the SEC for 9 companies · SOLANA BEACH, CA
Transactions
50
Companies
9
Filings
10
CIK
0001465914
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2024-09-03 | TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)J Other | — |
| 2024-06-11 | iTeos Therapeutics, Inc.Stock Option (Right to Buy)A Award | — |
| 2024-01-26 | Rain Oncology Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2024-01-26 | Rain Oncology Inc.U Disposition from Tender | — |
| 2024-01-26 | Rain Oncology Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2024-01-23 | Mirati Therapeutics, Inc.Option to Purchase Common StockD Disposition to Issuer | — |
| 2024-01-23 | Mirati Therapeutics, Inc.Option to Purchase Common StockD Disposition to Issuer | — |
| 2024-01-23 | Mirati Therapeutics, Inc.Option to Purchase Common StockD Disposition to Issuer | — |
| 2024-01-23 | Mirati Therapeutics, Inc.D Disposition to Issuer | — |
| 2024-01-23 | Mirati Therapeutics, Inc.D Disposition to Issuer | — |
| 2024-01-23 | Mirati Therapeutics, Inc.D Disposition to Issuer | — |
| 2023-12-29 | Mirati Therapeutics, Inc.A Award | +$400K |
| 2023-08-09 | Rain Oncology Inc.Stock Option (Right to Buy)A Award | — |
| 2023-06-13 | iTeos Therapeutics, Inc.Stock Option (Right to Buy)A Award | — |
| 2023-06-06 | TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-06-06 | TNGXTango Therapeutics, Inc.A Award | — |
| 2023-01-20 | Mirati Therapeutics, Inc.Non Qualified Stock Option (right to buy)A Award | — |
| 2023-01-20 | Mirati Therapeutics, Inc.A Award | — |
| 2022-11-04 | Rain Oncology Inc.Non-Voting Common StockP Purchase | +$2.33M |
| 2022-11-04 | Rain Oncology Inc.P Purchase | +$5.67M |
| 2022-06-09 | iTeos Therapeutics, Inc.Stock Option (Right to Buy)A Award | — |
| 2022-06-08 | TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2022-06-01 | Rain Oncology Inc.Stock Option (Right to Buy)A Award | — |
| 2022-05-11 | iTeos Therapeutics, Inc.S Sale | −$6.15M |
| 2022-05-11 | iTeos Therapeutics, Inc.S Sale | −$15.6K |
| 2022-05-10 | iTeos Therapeutics, Inc.S Sale | −$2.4M |
| 2022-05-10 | iTeos Therapeutics, Inc.S Sale | −$120K |
| 2022-05-09 | iTeos Therapeutics, Inc.S Sale | −$573K |
| 2022-05-09 | iTeos Therapeutics, Inc.S Sale | −$4.69M |
| 2022-05-02 | iTeos Therapeutics, Inc.S Sale | −$196K |
| 2022-05-02 | iTeos Therapeutics, Inc.S Sale | −$2.55M |
| 2022-04-29 | iTeos Therapeutics, Inc.S Sale | −$3.11M |
| 2022-04-29 | iTeos Therapeutics, Inc.S Sale | −$282K |
| 2022-04-28 | iTeos Therapeutics, Inc.S Sale | −$4.11M |
| 2022-03-23 | iTeos Therapeutics, Inc.P Purchase | +$657K |
| 2022-03-22 | iTeos Therapeutics, Inc.P Purchase | +$167K |
| 2022-03-22 | iTeos Therapeutics, Inc.P Purchase | +$679K |
| 2022-03-22 | iTeos Therapeutics, Inc.P Purchase | +$122K |
| 2022-01-14 | Mirati Therapeutics, Inc.A Award | — |
| 2022-01-14 | Mirati Therapeutics, Inc.Non Qualified Stock Option (right to buy)A Award | — |
| 2021-11-19 | Odonate Therapeutics, Inc.S Sale | −$276K |
| 2021-11-19 | Odonate Therapeutics, Inc.S Sale | −$57.5K |
| 2021-11-18 | Odonate Therapeutics, Inc.S Sale | −$487K |
| 2021-11-17 | Odonate Therapeutics, Inc.S Sale | −$1.3M |
| 2021-11-17 | Odonate Therapeutics, Inc.S Sale | −$380K |
| 2021-06-17 | iTeos Therapeutics, Inc.Stock Option (Right to Buy)A Award | — |
| 2021-04-27 | Rain Oncology Inc.Series B Preferred StockC Conversion | — |
| 2021-04-27 | Rain Oncology Inc.P Purchase | +$17.4M |
| 2021-04-27 | Rain Oncology Inc.Series B Preferred StockC Conversion | — |
| 2021-04-27 | Rain Oncology Inc.Non-Voting Common StockC Conversion | — |
Recent filings
- 4Davis Aaron I.0000895345-24-000369SEC(opens sec.gov)
- 4Davis Aaron I.0000950170-24-073255SEC(opens sec.gov)
- 4Davis Aaron I.0001999371-24-000965SEC(opens sec.gov)
- 4Davis Aaron I.0001140361-24-003538SEC(opens sec.gov)
- 4Davis Aaron I.0001628280-24-000357SEC(opens sec.gov)
- 4Davis Aaron I.0001104659-23-090698SEC(opens sec.gov)
- 4Davis Aaron I.0001209191-23-037587SEC(opens sec.gov)
- 4Davis Aaron I.0000899243-23-015012SEC(opens sec.gov)
- 4Davis Aaron I.0001214659-23-001050SEC(opens sec.gov)
- 4Davis Aaron I.0000899243-22-035366SEC(opens sec.gov)
Companies
- ARADIGM CORP10% Owner
- iTeos Therapeutics, Inc.Director
- Mirati Therapeutics, Inc.See remarks
- Odonate Therapeutics, Inc.Director, 10% Owner
- Pandion Therapeutics, Inc.10% Owner
- PMV Pharmaceuticals, Inc.Former 10% OwnerPMVP
- Rain Oncology Inc.Director
- Tango Therapeutics, Inc.See remarksTNGX
- Tyra Biosciences, Inc.See RemarksTYRA
Address
440 STEVENS AVE, SUITE 100
SOLANA BEACH, CA, 92075